APOE and dementia: The excess reduction in cortical volume with increased CDR scores in the apoE[ε4ε4,ε3ε4] group is in line with robust evidence of apoE4 as a key genetic risk factor for dementia54–56, accounting for 7% of overall dementia risk57.